Page last updated: 2024-12-06

nafenodone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

nafenodone: RN refers to (S)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID174100
CHEMBL ID2107645
SCHEMBL ID2109144
MeSH IDM0193080

Synonyms (17)

Synonym
nafenodone
nafenodonum
(+-)-2-(2-(dimethylamino)ethyl)-3,4-dihydro-2-phenyl-1(2h)-naphthalinon
nafenodone [inn]
0o501r1csq ,
(+-)-2-(2-(dimethylamino)ethyl)-3,4-dihydro-2-phenyl-1(2h)-naphthalenone
92615-20-8
unii-0o501r1csq
CHEMBL2107645
1(2h)-naphthalenone, 2-(2-(dimethylamino)ethyl)-3,4-dihydro-2-phenyl-
1(2h)-naphthalenone, 2-(2-(dimethylamino)ethyl)-3,4-dihydro-2-phenyl-, (+/-)-
(+/-)-2-(2-(dimethylamino)ethyl)-3,4-dihydro-2-phenyl-1(2h)-naphthalenone
SCHEMBL2109144
2-[2-(dimethylamino)ethyl]-2-phenyl-3,4-dihydronaphthalen-1-one
Q27237026
2-[2-(dimethylamino)ethyl]-2-phenyl-3,4-dihydronaphthalen-1(2h)-one
DTXSID10869100
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (16.67%)4.05%
Observational0 (0.00%)0.25%
Other4 (66.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]